An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west
Proc Natl Acad Sci U S A
.
2019 Jun 25;116(26):12611-12612.
doi: 10.1073/pnas.1907142116.
Authors
Thirumalaisamy P Velavan
1
2
3
,
David Nderu
4
5
,
Tsiri Agbenyega
6
7
8
,
Francine Ntoumi
4
9
,
Peter G Kremsner
4
10
Affiliations
1
Institut für Tropenmedizin, Universitätsklinikum Tübingen, 72074 Tübingen, Germany; velavan@medizin.uni-tuebingen.de.
2
Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
3
Faculty of Medicine, Duy Tan University, Da Nang, Vietnam.
4
Institut für Tropenmedizin, Universitätsklinikum Tübingen, 72074 Tübingen, Germany.
5
School of Health Sciences, Kirinyaga University, 10300 Kerugoya, Kenya.
6
Department of Physiology, School of Medical Sciences, University of Science and Technology, 00233 Kumasi, Ghana.
7
Department of Child Health, Komfo Anokye Teaching Hospital, 00233 Kumasi, Ghana.
8
Department of Medicine, Komfo Anokye Teaching Hospital, 00233 Kumasi, Ghana.
9
Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo.
10
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
PMID:
31239363
PMCID:
PMC6601264
DOI:
10.1073/pnas.1907142116
No abstract available
Publication types
Letter
Comment
MeSH terms
4-Butyrolactone / analogs & derivatives
Artemisinins*
Microfilament Proteins
Mutation
Plasmodium falciparum*
Substances
Artemisinins
Microfilament Proteins
coronin
4-Butyrolactone